Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvesco Perp Uk Regulatory News (IPU)

Share Price Information for Invesco Perp Uk (IPU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 418.50
Bid: 417.00
Ask: 420.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.719%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 418.50
IPU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

25 Oct 2018 16:41

Invesco Perpetual UK Smaller Co's Investment Trust Plc - Half-year Report

Invesco Perpetual UK Smaller Co's Investment Trust Plc - Half-year Report

PR Newswire

London, October 25

Invesco Perpetual UK Smaller Companies Investment Trust plc

Half-Yearly Financial Report for the Six Months to 31 July 2018

KEY FACTS

Investment Objective and Policies of the Company

The Company is an investment trust whose investment objective is to achieve long-term total return for shareholders primarily by investment in a broad cross-section of small to medium sized UK quoted companies.

The portfolio primarily comprises shares traded on the London Stock Exchange and on AIM.

The Company’s dividend policy is to distribute all available revenue earned by the portfolio in the form of dividends and the Board has approved the use of capital reserves to enhance dividend payments.

Full details of the Company’s investment and dividend policies, as well as the Company’s risk and investment limits, can be found in the annual financial report for the year ended 31 January 2018.

Financial Highlights

The Benchmark Index of the Company is the Numis Smaller Companies Index (excluding Investment Companies) with income reinvested.

ATAT
31 JUL31 JAN%
Period End Date20182018 CHANGE
Net asset value (NAV) per share546.8p543.6p+0.6
Share price(1)528.0p520.0p+1.5
Discount3.4%4.3%
Gearing and Net Cash:
– gross gearing(2)nilnil
– net gearing(3)nilnil
– net cash(4)3.2%3.1%
Maximum authorised gearing(5)8.4%8.4%

Total return (with income reinvested) for the six months ended 31 July 2018(1):

Net asset value per share(5)+3.2%
Share price(5)+4.3%
Benchmark Index+2.3%
FTSE All-Share Index+5.0%

Return and dividend per ordinary share SIX MONTHS ENDED

31 JUL31 JUL
20182017
(RESTATED)(6)
Return:
– revenue5.65p4.35p
– capital11.28p59.83p
– total16.93p64.18p
First interim dividend3.65p 3.55p
Notes:

(1) Source: Refinitiv (Thomson Reuters).(2) Gross gearing: borrowings ÷ shareholders’ funds.(3) Net gearing: borrowings less cash and cash equivalents ÷ shareholders’ funds.(4) Net cash: net exposure to cash and cash equivalents ÷ shareholders’ funds.(5) Defined in the Glossary of Terms and Alternative Performance Measures on pages 63 and 64 of the 2018 annual financial report.(6) Restated for tender offer costs reclassified to capital reserve, see note 1(b) to the Condensed Financial Statements.

CHAIRMAN’S STATEMENT INCORPORATING THE INTERIM MANAGEMENT REPORT

Chairman’s Statement

Over the six months to 31 July 2018, on a total return basis, your Company’s net asset value (NAV) increased by 3.2% compared with 2.3% for its benchmark, the Numis Smaller Companies Index (excluding Investment Companies). Over the same period the wider UK stock market outperformed the small cap market, with the FTSE All-Share Index achieving a higher return of 5.0%. A detailed review of the investment portfolio and strategy for the period is set out in the Portfolio Manager’s Report that follows.

The Company’s share price rose from 520p to 528p during the same period, an increase of 1.5% (4.3% on total return basis), and the discount to NAV ended the period at 3.4%, having been 4.3% at the January 2018 year end.

Since the Company’s half-year end, the smaller companies sector and the wider UK stock market have performed poorly with recent sharp falls and this has adversely impacted the Company’s performance. Over the period since 1 February 2018 to 23 October 2018, the latest practical date before publication, the Company’s NAV total return is –7.5%, the share price total return is –7.5%, whilst the benchmark total return is –7.4%. As at 23 October 2018, the discount was 4.5%, which is broadly similar to the last financial year end and continues to compare favourably with the UK Smaller Companies average of 11.5%.

Dividends

In accordance with the Company’s dividend policy, on 20 July 2018 the Board declared a first interim dividend of 3.65p for the year ending 31 January 2019, payable on 3 September 2018 to shareholders on the register on 3 August 2018 (2018: 3.55p).

The expected timetable for the remaining dividend payments is: second and third interim dividends in December 2018 and March 2019 respectively, with the final dividend payable in June 2019 following its approval by shareholders at the Company’s Annual General Meeting.

Outlook

As noted in the Portfolio Manager’s Report, the outcome of Brexit negotiations and impact of US trade policy with the rest of the world create an uncertain outlook and the potential for economic and market disruption. The Company’s portfolio managers continue with their investment strategy to invest in good quality, growing and well managed companies and with the breadth and diversity of the smaller companies sector they continue to find attractive investment opportunities. Your Board wholly supports the portfolio managers’ approach to stock selection in this difficult political and economic environment.

Ian BarbyChairman25 October 2018

PORTFOLIO MANAGER’S REPORT

Investment Review

The six months under review has provided another period of positive returns for equity investors, despite increasing tensions around global trade. Smaller companies, as measured by the Numis Smaller Companies Index (excluding Investment Companies), saw gains of 2.3% on a total return basis. This performance lagged the wider UK equity market, with the FTSE All-Share Index increasing by 5.0% on a total return basis. The stronger oil price was the main contributor to this, with some of the larger constituents of the FTSE All-Share, such as BP and Royal Dutch Shell, performing well.

Portfolio Strategy and Review

Against this background, your Company saw an increase in its net asset value of 3.2% for the six months under review, in total return terms. The portfolio benefited from overweight positions in the industrial and technology sectors, but was hurt by its exposure to the financial sector. Within the smaller company sector, oil stocks benefited from a higher oil price but UK consumer related stocks, such as retailers and leisure stocks, remained out of favour. The UK economy continues to be held back by Brexit uncertainty. Sterling weakness continues to suppress consumer discretionary expenditure and businesses are delaying major decisions until there is a clearer picture of future trading arrangements.

At the individual stock level, the best performers included: Softcat (+54%), which is a software and hardware re-selling business. The company has benefited from increased cyber security spending and growth in e-commerce activity amongst its SME customer base. Faroe Petroleum (+34%) benefited from the higher oil price and some speculation that the company could be a takeover target. Animal drug business, Dechra Pharmaceuticals (+24%) continued to perform well, with recent acquisitions adding to its impressive level of organic growth. Although we still like the company, its recent strong run has provided us with the opportunity to take some profit. Premier Oil (+54%) was another beneficiary of a rising oil price, but it also increased production as it brought a new field on stream. Disappointments in the period included Arrow Global (-37%), which specialises in debt recovery. The stock fell out of favour with some investors who questioned its ability to acquire further books of business at attractive prices. Whilst the cost of acquisition has increased over the last couple of years, the returns the company can achieve remain attractive, so we have maintained our holding. Financial outsourcing business Equiniti (-20%) suffered due to accusations of aggressive accounting. Following meetings with both executive and non-executive management, we are comfortable that nothing improper has occurred and believe that the business still has significant growth opportunities.

New holdings added to the portfolio over the period include AJ Bell, an unquoted stock which we acquired from a forced seller at a very attractive price. It offers an online platform which enables investors to manage their portfolios, often via tax efficient wrappers such as personal pension schemes. The company has an excellent growth record, enjoys a high level of recurring revenue and is scheduled to list in the autumn. We have revisited Alfa Financial Software, which we owned briefly after its listing before taking a profit. The business is the clear global leader in providing asset leasing software to industrial and financial businesses. The stock declined 70% from its high after delays to new contracts, which prompted us to meet with management and visit their premises before buying a modest position. There is a risk of further disappointment, but we could potentially use a further fall in the shares to build a full position. We also participated in a number of initial public offerings including Amigo Loans, which has a dominant position in the guarantor loans market; JTC, which is a financial administration business based in Jersey; Nucleus Financial, which is a similar business to AJ Bell; and Energean which is an oil and gas business that has raised funds to develop a discovery in the Mediterranean.

The major holdings in the portfolio currently include Clinigen, which is a world leading specialist distributor of pharmaceuticals for use on an unlicensed and pre-approved basis. It also acquires the rights to drugs where there is potential to grow sales by extending usage of the product through further regulatory approvals. The business has a good record of growing profits and has plenty of future potential. Also within the healthcare sector we continue to own Consort Medical, which manufactures medical devices. The company has developed a novel auto-injector which is perfectly suited to administering the new generation of “biologic” drugs, which are more viscous than traditional medicines. The product, which is currently being trialled by a major pharmaceutical business, could be a substantial driver of growth. Within the highly diverse industrial sector we have retained a significant position in Coats, which is a global leader in the supply of thread to the clothing industry, but is also developing a range of high tech fibres which are used in high performance application in the automotive and telecoms sectors; Robert Walters, a recruitment company with offices around the world; and RWS, which is a world leader in language translation and intellectual property services.

Our investment strategy remains unchanged. The current portfolio comprises of around 80 stocks, with the sector weightings being determined by where we are finding attractive companies at a given time, rather than by allocating assets according to a “top down” view of the economy. We continue to seek growing business, which have the potential to be significantly larger in the medium term. These tend to be companies that either have great products or services, that can enable them to take market share from their competitors, or companies that are exposed to higher growth niches within the UK economy or overseas. We prefer to invest in cash generative businesses that can fund their own expansion, although we are willing to back strong management teams by providing additional capital to invest for growth.

Our analysis remains focused on the sustainability of returns and profit margins, which are vital for the long term success of a company. We continue to look for businesses with “pricing power” by assessing positioning within supply chains and having a clear understanding of how work is won and priced. It is also important to determine which businesses possess unique capabilities, in the form of intellectual property, specialist know-how or a scale advantage in their chosen market. We conduct around 350 company meetings and site visits a year, and these areas are a particular focus for us on such occasions.

Outlook

The biggest potential risk to the global economy emanates from the mistaken belief that economic prosperity can be enhanced by rejecting free trade. This has strong parallels with the policies enacted during the great depression of the 1930’s (e.g. the Smoot–Hawley Tariff Act). The policies seem to garner support from electorates, as they are seen as simple solutions to complex problems but history shows that, whilst the impact can be positive initially, ultimately it is destructive to economic activity and prosperity. Whilst we remain hopeful of a reasonable outcome to the Brexit negotiations and that the US will de-escalate its trade war with the rest of the world, the potential for economic and market disruption looms large. With many markets close to all-time highs, there appears to be a degree of complacency amongst investors about the current predicament.

In light of this uncertainty, we favour stocks with “self-help” characteristics that enable them to grow independently of the economy. This can include the restructuring of underperforming businesses, sector consolidation, roll-out strategies or market share gains led by innovation. Fortunately, the breadth and diversity of the smaller companies sector enables us to find a steady stream of such investments. Therefore, despite the uncertain outlook, we remain hopeful of achieving an acceptable return for our shareholders.

Jonathan Brown Robin WestPortfolio Manager Deputy Portfolio Manager25 October 2018

PRINCIPAL RISKS AND UNCERTAINTIES

– Market (Economic) Risk – factors such as general fluctuations in stock markets, interest rates and exchange rates may give rise to high levels of volatility in the share prices of investee companies, as well as affecting the Company’s own share price and discount to NAV.

– Investment Risk – the Company invests in small and medium-sized companies traded on the London Stock Exchange or on AIM. By their nature these are generally considered riskier than their larger counterparts and their share prices can be more volatile, with lower liquidity. There can be no guarantee that the Company will achieve its published investment objective.

– Shareholders’ Risk – The value of an investment in the Company may go down as well as up and an investor may not get back the amount invested.

– Borrowings – the Company may borrow money for investment purposes. If the investments fall in value, any borrowings (or gearing) will magnify any loss. If the borrowing facility could not be renewed, the Company might have to sell investments to repay any borrowings it has.

– Reliance on the Manager and other Third Party Providers – failure by any third party provider to carry out its obligations to the Company could have a materially detrimental impact on the operation of the Company and could affect the ability of the Company to successfully pursue its investment policy.

– Regulatory Risk – the Company is subject to various laws and regulations by virtue of its status as an investment trust. Control failures by any of the third party providers may result in operational or reputational problems, erroneous disclosures or loss of assets through fraud, as well as breaches of regulations.

A detailed explanation of these principal risks and uncertainties can be found on pages 9 and 10 of the Company’s 2018 annual financial report, which is available on the Company’s section of the Manager’s website at: www.invesco.co.uk/ipukscit

In the view of the Board, these principal risks and uncertainties are as much applicable to the remaining six months of the financial year as they were to the six months under review.

GOING CONCERN

The financial statements have been prepared on a going concern basis. The Directors consider this is the appropriate basis, as the Company has adequate resources to continue in operational existence for the foreseeable future. In considering this, the Directors took into account the diversified portfolio of readily realisable securities which can be used to meet funding commitments, and the ability of the Company to meet all of its liabilities, including any bank overdraft, and ongoing expenses.

RELATED PARTY TRANSACTIONS AND TRANSACTIONS WITH THE MANAGER

Note 21 of the 2018 annual report gives details of related party transactions and transactions with the Manager. This report is available on the Company’s section of the Manager’s website at www.invesco.co.uk/ipukscit.

DIRECTORS, ADVISERS AND PRINCIPAL SERVICE PROVIDERS

DirectorsIan Barby (Chairman of the Board and Nomination Committee)Richard Brooman (Deputy Chairman, Chairman of theAudit Committee and Senior Independent Director)Christopher FletcherBridget Guerin – appointed 8 May 2018Jane Lewis (Chairman of the Management Engagement Committee)

Alternative Investment Fund Manager (Manager)Invesco Fund Managers Limited

Registered OfficePerpetual Park, Perpetual Park DriveHenley-on-Thames, Oxfordshire RG9 1HH

Company NumberRegistered in England and Wales No. 02129187

Company Secretary and Correspondence AddressInvesco Asset Management Limited6th Floor, 125 London WallLondon EC2Y 5AS020 3753 1000Company Secretarial contact: Kelly Nice

Invesco Client ServicesInvesco’s Client Services Team is available from 8.30 am to 6.00pm Monday to Friday (excluding UK bank holidays).Please note no investment advice can be given.0800 085 8677www.invesco.co.uk/investmenttrusts

DepositaryThe Bank of New York Mellon (International) Limited1 Canada SquareLondon E14 5AL

Independent AuditorGrant Thornton UK LLP30 Finsbury Square, London EC2P 2YU

RegistrarLink Asset Services, The Registry, 34 Beckenham Road, Kent BR3 4TUIf you hold shares directly, have a query relating to your shares and you hold the shares in your own name, you should contact the registrar on:0871 664 0300Calls cost 12p per minute plus network extras.+44 371 664 0300 (from outside the UK).Lines are open Monday to Friday 9.00am to 5.30pm (excluding UK bank holidays).Shareholders holding shares directly can also access their holding details via Link’s website: www.signalshares.comThe registrar provides an online and telephone share dealing servicefor existing shareholders who are not seeking advice on buying or selling.The website is: www.linksharedeal.com or 0371 664 0445Calls are charged at the standard geographic rate and will vary by provider. +44 371 664 0300 (from outside the UK). Lines are open Monday to Friday 8.00am to 4.30pm (excluding UK bank holidays).

Manager’s Website

Information relating to the Company can be found on the Company’s page of the Manager’s website at www.invesco.co.uk/ipukscit.The contents of websites referred to in this document, or accessible links within those websites, are not incorporated into, nor do they form part of, this document.

General Data Protection Regulation

The Company’s privacy notice can be found at www.invesco.co.uk/ipukscit

THIRTY LARGEST HOLDINGS AT 31 JULY 2018

Ordinary shares unless stated otherwise

MARKET
VALUE% OF
ISSUERACTIVITY BY SECTOR£’000PORTFOLIO
CoatsGeneral Industrials 4,3252.5
ClinigenAIMPharmaceuticals & Biotechnology 4,2882.5
Consort MedicalHealth Care Equipment & Services 4,0092.3
Robert WaltersSupport Services 4,0092.3
4imprintMedia 3,9762.3
RWSAIMSupport Services 3,7622.2
Ultra ElectronicsAerospace & Defence 3,5462.0
SanneSupport Services 3,4902.0
SafestoreReal Estate Investment Trusts 3,4642.0
Johnson ServiceAIMSupport Services 3,4101.9
FutureMedia 3,3401.9
Fisher (James) & SonsIndustrial Transportation 3,2801.9
VpSupport Services 3,2541.9
EquinitiSupport Services 3,2091.8
Faroe PetroleumAIMOil & Gas Producers 3,1691.8
Euromoney Institutional InvestorMedia 3,0751.7
CVSAIMGeneral Retailers 3,0561.7
St. Modwen PropertiesReal Estate Investment & Services 2,9571.7
PolypipeConstruction & Materials 2,9321.7
Hill & SmithIndustrial Engineering 2,8891.7
M&C SaatchiAIMMedia 2,8571.6
Hilton FoodFood Producers 2,8411.6
JTCFinancial Services 2,6221.5
Keywords StudiosAIMSupport Services 2,6031.5
TarsusMedia 2,5451.5
SavillsReal Estate Investment & Services 2,5301.4
StafflineAIMSupport Services 2,4871.4
FDMSoftware & Computer Services 2,4371.4
MicrogenSoftware & Computer Services 2,4311.4
SoftcatSoftware & Computer Services 2,4161.3
 95,20954.4
Other Investments (51) 79,72845.6
Total Investments (81) 174,937100.0

AIM Investments quoted on AIM.

CONDENSED STATEMENT OF COMPREHENSIVE INCOME

SIX MONTHS TO 31 JUL 2018SIX MONTHS TO 31 JUL 2017
REVENUE CAPITALTOTALREVENUECAPITALTOTAL
(RESTATED)*(RESTATED)*
£’000£’000£’000£’000£’000£’000
Profits on investments held at fair value — 4,582  4,582  33,370 33,370
Exchange differences(9)(9)
Income – note 2 2,145  —  2,145  2,577 2,577
 2,145  4,582  6,727 2,577 33,361 35,938
Investment management fee – note 3(86)(486)(572)(128)(727)(855)
Performance fee – note 3 —(385)(385)(1,127)(1,127)
Other expenses(202)(1)(203)(159)(2)(161)
Profit before finance costs and taxation 1,857  3,710  5,567  2,29031,505 33,795
Finance costs – note 3(1)(5)(6)(1)(5)(6)
Profit before taxation 1,856  3,705  5,561  2,28931,500 33,789
Taxation – note 4
Profit after taxation 1,856  3,705  5,561  2,28931,500 33,789
Return per ordinary share – basic5.65p 11.28p 16.93p 4.35p59.83p64.18p
Weighted average number of
ordinary shares in issue32,851,92952,646,732

*See note 1(b) to the Condensed Financial Statements.

The total column of this statement represents the Company’s statement of comprehensive income, prepared in accordance with International Financial Reporting Standards as adopted by the European Union. The profit after taxation is the total comprehensive income. The supplementary revenue and capital columns are both prepared in accordance with the Statement of Recommended Practice issued by the Association of Investment Companies. All items in the above statement derive from continuing operations of the Company. No operations were acquired or discontinued in the period.

CONDENSED BALANCE SHEET

Registered number 2129187

ATAT
31 JUL31 JAN
20182018
£’000£’000
Non-current assets
Investments at fair value through
profit or loss174,937176,074
Current assets
Amounts due from brokers34
Prepayments and accrued income264234
Cash and cash equivalents5,7655,500
6,0295,768
Total assets180,966181,842
Current liabilities
Amounts due to brokers — (492)
Performance fee accrued - note 3 (1,811)
Other accruals (165) (183)
 (165) (2,486)
Total assets less current liabilities180,801179,356
Provision for performance fee
– note 3 (1,170) (785)
Net assets179,631178,571
Capital and reserves
Share capital10,64210,642
Share premium21,24421,244
Capital redemption reserve3,3863,386
Capital reserve142,503142,058
Revenue reserve1,8561,241
Shareholders' funds  179,631178,571
Net asset value per ordinary share 546.8p 543.6­p
Number of 20p ordinary shares in issue at the period end - note 732,851,92932,851,929

CONDENSED STATEMENT OF CASH FLOW

SIX SIX
MONTHS TOMONTHS TO
31 JUL31 JUL
20182017
(RESTATED)*
£’000£’000
Cash flow from operating activities
Profit before finance costs and taxation 5,567 33,795
Adjustments for:
Purchases of investments(15,137)(39,871)
Sales of investments 20,398 140,828
 5,261 100,957
Profit on investments at fair value(4,582)(33,370)
(Increase)/decrease in receivables(30)46
(Decrease)/increase in payables(1,429)906
Net cash inflow from operating activities 4,787 102,334
Cash flow from financing activities
Finance cost paid(21)(6)
Share buy back costs from tender offer(100,139)
Equity dividends paid – note 5(4,501)(5,427)
Net cash outflow from financing activities(4,522)(105,572)
Net increase/(decrease) in cash and cash equivalents 265 (3,238)
Cash and cash equivalents at the at the start of the period 5,500 7,408
Cash and cash equivalents at the end of the period 5,765 4,170
Reconciliation of cash and cash equivalents to the Balance Sheet is as follows:
Cash held at custodian1951,140
Short-Term Investment Company (Global
Series) plc, money market fund5,5703,030
Cash and cash equivalents 5,765 4,170
Cash flow from operating activities includes:
Dividends received2,1192,607
Interest received8

CONDENSED STATEMENT OF CHANGES IN EQUITY

CAPITAL
SHARESHAREREDEMPTIONCAPITALREVENUE
CAPITALPREMIUMRESERVERESERVERESERVETOTAL
£’000£’000£’000£’000£’000£’000
For the six months ended 31 July 2018
At 31 January 2018 10,642  21,244  3,386  142,058  1,241  178,571
Total comprehensive income for the period  —  —  3,705  1,856  5,561
Dividends paid – note 5 — — —(3,260)(1,241)(4,501)
At 31 July 2018 10,642  21,244  3,386  142,503  1,856  179,631
For the six months ended 31 July 2017
At 31 January 2017 10,642 21,244 3,386 206,079 252 241,603
Total comprehensive income for the period (restated)* — — — 31,500 2,289 33,789
Tendered shares bought back and held
in treasury (restated)*(100,139)(100,139)
Dividends paid – note 5(5,175)(252)(5,427)
At 31 July 2017 10,642 21,244 3,386 132,265 2,289 169,826

*See note 1(b) to the Condensed Financial Statements.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

1(a) Basis of Preparation

Accounting Standards and Policies

The condensed financial statements have been prepared using the same accounting policies as those adopted in the 2018 annual financial report. They have been prepared on an historical cost basis, in accordance with the applicable International Financial Reporting Standards (IFRS), as adopted by the European Union and, where possible, in accordance with the Statement of Recommended Practice for Financial Statements of Investment Trust Companies and Venture Capital Trusts, issued by the Association of Investment Companies in November 2014, as updated in February 2018.

(b) Restatement of 31 July 2017 comparative amounts

Comparative amounts at 31 July 2017, have been restated to reflect the reclassification of £493,000 or 0.93p per share of tender offer costs, previously accounted for in the Condensed Statement of Comprehensive Income (capital), to the Condensed Statement of Changes in Equity (capital reserve). The effect is an increase in the capital profit after tax and return per share from £31,007,000 (58.90p) to £31,500,000 (59.83p); and the total profit after tax and return per share from £33,296,000 (63.25p) to £33,789,000 (64.18p) as shown in the Condensed Statement of Comprehensive Income.

The effect of the above restatement on the Condensed Statement of Changes in Equity is an increase in total comprehensive income for the period from £33,296,000 to £33,789,000 and an increase in the cost of tendered shares bought back and held in treasury from £99,646,000 to £100,139,000 with no impact on the total amount of capital reserve or net assets as reported in the Balance Sheet as at 31 July 2017.

2. Income

31 JUL31 JUL
20182017
SIX MONTHS ENDED£’000£’000
Income from listed investments:
UK dividends 1,695 2,173
UK unfranked investment income 134 161
Overseas dividends 105 173
Special dividends 211 62
 2,145 2,569
Other income:
Deposit interest8
 2,145 2,577

3. Management and Performance Fees and Finance Costs

Investment management fee and finance costs are allocated 15% to revenue and 85% to capital.

Performance fees are charged wholly to capital. An amount of £385,000 has been provided for the six months to 31 July 2018 (six months to 31 July 2017: £1,127,000; year to 31 January 2018: £2,596,000). The performance fee payable in any year is capped at 1% of average funds under management, with any excess (subject to a total performance fee cap of 2%) carried forward. The excess brought forward from the year ended 31 January 2018 of £785,000 is included in the balance sheet, and the NAV, as a provision for performance fee.

4. Taxation and Investment Trust Status

No tax liability arises on capital gains because the Company has been accepted by HMRC as an approved investment trust and it is the intention of the Directors to conduct the affairs of the Company so that it continues to satisfy the conditions for this approval.

5. Dividends paid on Ordinary Shares

31 JULY 201831 JULY 2017
SIX MONTHS ENDEDRATE£’000RATE£’000
Third interim3.55p 1,166 3.45p 1,836
Final10.15p 3,335 6.75p 3,591
Total13.70p 4,501 10.20p 5,427

The first interim dividend of 3.65p per ordinary share for the year ended 31 January 2019 (2018: 3.55p) was paid on 3 September 2018 to shareholders on the register on 3 August 2018.

6. Tender Offer

No shares were repurchased during the six month period ended 31 July 2018. For the period ended 31 July 2017, as a result of the tender offer, a total of 20,357,155 shares were repurchased and held in treasury by the Company on 27 July 2017 at a tender offer price of 487.05p. In addition, fixed costs and stamp duty of £988,000 were also incurred on completion of the tender offer.

7. Share capital movements

SIX MONTHSSIX MONTHS
TOTO
31 JUL31 JUL
20182017
Share capital:
Ordinary shares of 20p each (£’000) 6,571 6,571
Treasury shares of 20p each (£’000) 4,071 4,071
 10,642 10,642
Number of ordinary shares in issue:
Brought forward 32,851,929 53,209,084
Tendered shares bought back into treasury(20,357,155)
 32,851,929 32,851,929

8. Classification Under Fair Value Hierarchy

Note 17 of the 2018 annual financial report sets out the basis of classification.

As at 31 July 2018, the majority of the Company’s portfolio was composed of quoted (Level 1) investments. The following unquoted (Level 3) investments were also held at the period end: AJ Bell valued at £1,721,000 (31 January 2018: not held) and Berry Starquest Limited (dormant subsidiary) valued at £100 (31 January 2018: £100).

9. Status of Half-Yearly Financial Report

The financial information contained in this half-yearly financial report, which has not been reviewed or audited by an independent auditor, does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The financial information for the half years ended 31 July 2017 and 31 July 2018 has not been audited. The figures and financial information for the year ended 31 January 2018 are extracted and abridged from the latest audited accounts and do not constitute the statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and included the Independent Auditor's Report, which was unqualified.

By order of the Board

Invesco Asset Management Limited

Company Secretary 25 October 2018

STATEMENT OF DIRECTORS’ RESPONSIBILITIES

in respect of the preparation of the half-yearly financial report.

The Directors are responsible for preparing the half-yearly financial report using accounting policies consistent with applicable law and International Financial Reporting Standards.

The Directors confirm that to the best of their knowledge:

– the condensed set of financial statements contained within the half-yearly financial report have been prepared in accordance with the International Accounting Standards 34 ‘Interim Financial Reporting’;

– the interim management report includes a fair review of the information required by 4.2.7R and 4.2.8R of the UKLA’s Disclosure Guidance and Transparency Rules; and

– the interim management report includes a fair review of the information required on related party transactions.

The half-yearly financial report has not been audited or reviewed by the Company’s auditor.

Signed on behalf of the Board of Directors.

Ian BarbyChairman 25 October 2018

Date   Source Headline
3rd May 202411:19 amPRNNet Asset Value(s)
2nd May 202412:52 pmPRNNet Asset Value(s)
1st May 20244:56 pmPRNDirector/PDMR Shareholding
1st May 20243:45 pmPRNDirector/PDMR Shareholding
1st May 20241:23 pmPRNPortfolio Update
1st May 202412:23 pmPRNDirector/PDMR Shareholding
1st May 202411:45 amPRNNet Asset Value(s)
1st May 20247:00 amPRNAnnual Financial Report
30th Apr 202411:31 amPRNNet Asset Value(s)
29th Apr 202411:49 amPRNNet Asset Value(s)
26th Apr 202412:05 pmPRNNet Asset Value(s)
25th Apr 202412:14 pmPRNNet Asset Value(s)
24th Apr 202411:59 amPRNNet Asset Value(s)
23rd Apr 202411:36 amPRNNet Asset Value(s)
22nd Apr 202411:47 amPRNNet Asset Value(s)
19th Apr 202411:14 amPRNNet Asset Value(s)
18th Apr 202411:54 amPRNNet Asset Value(s)
17th Apr 202411:36 amPRNNet Asset Value(s)
16th Apr 202411:37 amPRNNet Asset Value(s)
15th Apr 202411:23 amPRNNet Asset Value(s)
12th Apr 202411:35 amPRNNet Asset Value(s)
11th Apr 202411:51 amPRNNet Asset Value(s)
10th Apr 20245:10 pmPRNHolding(s) in Company
10th Apr 202411:42 amPRNNet Asset Value(s)
9th Apr 202411:27 amPRNNet Asset Value(s)
8th Apr 202411:39 amPRNNet Asset Value(s)
5th Apr 202412:17 pmPRNNet Asset Value(s)
4th Apr 202411:52 amPRNNet Asset Value(s)
3rd Apr 20242:04 pmPRNPortfolio Update
3rd Apr 202411:48 amPRNNet Asset Value(s)
2nd Apr 202411:51 amPRNNet Asset Value(s)
28th Mar 202411:46 amPRNNet Asset Value(s)
27th Mar 202411:58 amPRNNet Asset Value(s)
26th Mar 202411:23 amPRNNet Asset Value(s)
25th Mar 202411:53 amPRNNet Asset Value(s)
22nd Mar 20244:37 pmRNSQuotedData's Weekly News & Interview
22nd Mar 202411:48 amPRNNet Asset Value(s)
21st Mar 202411:34 amPRNNet Asset Value(s)
20th Mar 202411:46 amPRNNet Asset Value(s)
19th Mar 202411:19 amPRNNet Asset Value(s)
18th Mar 202411:24 amPRNNet Asset Value(s)
15th Mar 202411:25 amPRNNet Asset Value(s)
14th Mar 202411:26 amPRNNet Asset Value(s)
13th Mar 202411:44 amPRNCompliance with Market Abuse Regulation
13th Mar 202411:22 amPRNNet Asset Value(s)
12th Mar 202411:59 amPRNNet Asset Value(s)
11th Mar 202411:51 amPRNNet Asset Value(s)
8th Mar 202411:50 amPRNNet Asset Value(s)
7th Mar 202411:46 amPRNNet Asset Value(s)
6th Mar 202411:45 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.